By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Asterias Biotherapeutics 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-433-2992 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" And Will Present At The Therapeutic Area Partnerships Conference 11/18/2014 1:05:47 PM
Asterias Biotherapeutics To Participate In Live Google Inc. Hangout Discussion Of Stem Cell-Based Therapies For Spinal Cord Injury 11/17/2014 11:44:59 AM
Asterias Biotherapeutics Reports Third Quarter Financial And Operating Results 11/11/2014 7:34:12 AM
Asterias Biotherapeutics To Report Third Quarter Results On November 10, 2014 10/31/2014 7:33:48 AM
Asterias Biotherapeutics Announces Notice Of Grant Award With CIRM For Phase 1/2a Clinical Trial Of AST-OPC1 In Complete Cervical Spinal Cord Injury 10/20/2014 8:11:10 AM
Asterias Biotherapeutics To List Its Series A Common Stock On NYSE MKT 10/7/2014 8:09:26 AM
Asterias Biotherapeutics Announces Distribution Date Of Biotime Warrants And Conversion Date Of Series B Common Stock Into Series A Common Stock 9/29/2014 11:31:52 AM
Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 9/11/2014 7:26:28 AM
Asterias Biotherapeutics Announces Record Date For Distribution Of BioTime (BTX) Warrants To Holders Of Asterias Series A Common Stock 9/8/2014 9:17:49 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Receives FDA Clearance To Initiate Phase 1/2a Clinical Trial Of AST-OPC1 In Patients With Cervical Complete Spinal Cord Injury 8/27/2014 10:56:06 AM
12
//-->